Literature DB >> 19403440

Continued family smoking after lung cancer diagnosis: the patient's perspective.

Joan L Bottorff1, Carole A Robinson, Kelli M Sullivan, Michelle L Smith.   

Abstract

PURPOSE/
OBJECTIVES: To explore the influence of lung cancer diagnosis on interpersonal dynamics in families in which one or more members continue to smoke following diagnosis. RESEARCH APPROACH: Descriptive, qualitative.
SETTING: Three cancer care sites in western Canada. PARTICIPANTS: 16 participants from 8 family dyads. METHODOLOGIC APPROACH: Patients with lung cancer receiving treatment and immediate family members were recruited to participate in individual or conjoint semistructured interviews. Thematic analysis was conducted on transcribed interviews. MAIN RESEARCH VARIABLES: Intrafamily interaction patterns, smoking and smoking cessation, lung cancer diagnosis.
FINDINGS: Following diagnosis, patients with lung cancer experienced considerable distress as they struggled to understand family members' continued smoking. Patient orientations to family members who smoked included preserving relationships (maintaining harmony and connection with family members took priority over directly intervening with smokers) and risking relationships (patients repeatedly confronted family members about continued smoking to influence their cessation despite the impact on relationships). Neither pattern was successful in engaging relatives in smoking reduction or cessation, and the risking relationships approach resulted in conflict and strained family relationships.
CONCLUSIONS: The findings provide additional support for examining family dynamics related to tobacco reduction and cessation as well as directions for future research.
INTERPRETATION: Nurses should encourage tobacco reduction as a supportive intervention for patients with lung cancer and their families to eliminate smoking-related distress.

Entities:  

Mesh:

Year:  2009        PMID: 19403440     DOI: 10.1188/09.ONF.E126-E132

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  8 in total

1.  Measuring stigma in people with lung cancer: psychometric testing of the cataldo lung cancer stigma scale.

Authors:  Janine K Cataldo; Robert Slaughter; Thierry M Jahan; Voranan L Pongquan; Won Ju Hwang
Journal:  Oncol Nurs Forum       Date:  2011-01       Impact factor: 2.172

2.  Smoking concordance in lung and colorectal cancer patient-caregiver dyads and quality of life.

Authors:  Kathryn E Weaver; Julia H Rowland; Erik Augustson; Audie A Atienza
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-12-21       Impact factor: 4.254

3.  Lung cancer stigma, depression, and quality of life among ever and never smokers.

Authors:  Janine K Cataldo; Thierry M Jahan; Voranan L Pongquan
Journal:  Eur J Oncol Nurs       Date:  2011-07-30       Impact factor: 2.398

Review 4.  Smoking cessation: an integral part of lung cancer treatment.

Authors:  Janine K Cataldo; Sarita Dubey; Jodi J Prochaska
Journal:  Oncology       Date:  2010-08-11       Impact factor: 2.935

5.  Why do cancer patients smoke and what can providers do about it?

Authors:  Sonia A Duffy; Samantha A Louzon; Ellen R Gritz
Journal:  Community Oncol       Date:  2012-11-17

6.  Reducing tobacco-related cancer incidence and mortality: summary of an institute of medicine workshop.

Authors:  Erin P Balogh; Carolyn Dresler; Mark E Fleury; Ellen R Gritz; Thomas J Kean; Matthew L Myers; Sharyl J Nass; Brenda Nevidjon; Benjamin A Toll; Graham W Warren; Roy S Herbst
Journal:  Oncologist       Date:  2013-12-04

7.  Impact of Family and Social Network on Tobacco Cessation Amongst Cancer Patients.

Authors:  Melissa Neumann; Neal Murphy; Nagashree Seetharamu
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

8.  Using a Family Systems Approach to Treat Tobacco Use among Cancer Patients.

Authors:  Ellen Ruebush; Sara Mitra; Colleen Meyer; Laurel Sisler; Adam O Goldstein
Journal:  Int J Environ Res Public Health       Date:  2020-03-19       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.